Personal information

Activities

Employment (2)

Fondazione IRCCS Istituto Nazionale dei Tumori: Milano, Lombardia, IT

2020-01-21 to present | Medical oncologist (Thoracic Oncology Unit, Medical Oncology Department)
Employment
Source: Self-asserted source
Giuseppe Viscardi

Università degli Studi della Campania Luigi Vanvitelli: Napoli, Campania, IT

2014-12-10 to present | MD Resident (Medical Oncology, Department of Precision Medicine)
Employment
Source: Self-asserted source
Giuseppe Viscardi

Education and qualifications (3)

Università degli Studi della Campania Luigi Vanvitelli: Napoli, IT

2019-11-04 to present | PhD Student in Translational Medicine (Department of Precision Medicine)
Education
Source: Self-asserted source
Giuseppe Viscardi

Università degli Studi della Campania Luigi Vanvitelli: Napoli, IT

2014-12-10 to 2019-12-17 | Specialty school of Medical Oncology (Department of Precision Medicine)
Education
Source: Self-asserted source
Giuseppe Viscardi

Università degli Studi della Campania Luigi Vanvitelli: Napoli, Campania, IT

2007-09 to 2013-10-10 | Degree in Medicine and Surgery (Department of Experimental Medicine)
Education
Source: Self-asserted source
Giuseppe Viscardi

Professional activities (3)

International Association for the Study of Lung Cancer: Aurora, CO, US

Membership
Source: Self-asserted source
Giuseppe Viscardi

European Society for Medical Oncology: Viganello, TI, CH

Membership
Source: Self-asserted source
Giuseppe Viscardi

Associazione Italiana di Oncologia Medica: Milano, Lombardia, IT

Membership
Source: Self-asserted source
Giuseppe Viscardi

Works (9)

Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies

European Journal of Cancer
2023-12 | Journal article
Contributors: Antonio Nuccio; Giuseppe Viscardi; Fabio Salomone; Alberto Servetto; Francesco Maria Venanzi; Silvia Teresa Riva; Sara Oresti; Francesca Rita Ogliari; Mariagrazia Viganò; Alessandra Bulotta et al.
Source: check_circle
Crossref

Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis

European Journal of Cancer
2022-12 | Journal article
Contributors: Giuseppe Viscardi; Antonino C. Tralongo; Francesco Massari; Matteo Lambertini; Veronica Mollica; Alessandro Rizzo; Francesca Comito; Raimondo Di Liello; Salvatore Alfieri; Martina Imbimbo et al.
Source: check_circle
Crossref

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review

Cancers
2022-11-25 | Journal article
Contributors: Giuseppe Viscardi; Fabiana Vitiello; Alberto Servetto; Valerio Gristina; Elio Gregory Pizzutilo; Maria Anna Canciello; Paola Maria Medusa; Fabio Salomone; Gaetano Di Guida; Mariano Mollica et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

Therapeutic Advances in Medical Oncology
2021-01 | Journal article
Contributors: Morena Fasano; Carminia Maria Della Corte; Giuseppe Viscardi; Raimondo Di Liello; Fernando Paragliola; Francesca Sparano; Maria Lucia Iacovino; Anna Castrichino; Francesca Doria; Antonello Sica et al.
Source: check_circle
Crossref

Circulating biomarkers in malignant pleural mesothelioma

Exploration of Targeted Anti-tumor Therapy
2020-12 | Journal article
Contributors: Giuseppe Viscardi; Davide Di Natale; Morena Fasano; Marta Brambilla; Riccardo Lobefaro; Alessandro De Toma; Giulia Galli
Source: check_circle
Crossref

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer

ESMO Open
2020-09 | Journal article
Contributors: Morena Fasano; Carminia Maria Della Corte; Raimondo Di Liello; Giusi Barra; Francesca Sparano; Giuseppe Viscardi; Maria Lucia Iacovino; Fernando Paragliola; Vincenzo Famiglietti; Vincenza Ciaramella et al.
Source: check_circle
Crossref

Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature

ESMO Open
2019-09 | Journal article
Contributors: Giuseppe Viscardi; Nicoletta Zanaletti; Maria Giovanna Ferrara; Antonello Sica; Umberto Falcone; Salvatore Guastafierro; Umberto Bracale; Dario Ribero; Morena Fasano; Stefania Napolitano et al.
Source: check_circle
Crossref

Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study

ESMO Open
2019-08 | Journal article
Contributors: Raimondo Di Liello; Vincenza Ciaramella; Giusi Barra; Massimo Venditti; Carminia Maria Della Corte; Federica Papaccio; Francesca Sparano; Giuseppe Viscardi; Maria Lucia Iacovino; Sergio Minucci et al.
Source: check_circle
Crossref

How I treat malignant pleural mesothelioma

ESMO Open
2019-03 | Journal article
Contributors: Giuseppe Viscardi; Raimondo Di Liello; Floriana Morgillo
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for Critical reviews in oncology/hematology. (1)
Review activity for Lung cancer. (1)